The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Pieris Pharmaceuticals, Inc(NASDAQ:PIRS) 
Pieris Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, discovers and develops anticalin-based drugs in the United States. The company develops anticalin proteins that are low molecular-weight therapeutic proteins derived from lipocalins, which are naturally occurring low-molecular...
Website: http://www.pieris.com
Founded: 2001
Full Time Employees: 114
Sector: Healthcare
Industry: Biotechnology
Pieris Pharmaceuticals Days Payable Outstanding ttm (DPO)
Pieris Pharmaceuticals Days Receivable Outstanding ttm (DSO)
Pieris Pharmaceuticals Days Inventory Outstanding ttm (DIO)
Pieris Pharmaceuticals Op Cashflow Per Share ttm
Pieris Pharmaceuticals Free Cashflow Per Share ttm
Pieris Pharmaceuticals Cash Per Share ttm
Pieris Pharmaceuticals P/S ratio ttm
Pieris Pharmaceuticals (GAAP) P/E ratio ttm
Pieris Pharmaceuticals P/B ratio ttm
No extra charts and metrics for this ticker.